Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Caroderma AB
AB
Active
Org 5592138696
Karlaplan 19 C, 115 20
Stockholm
Medical specialists activities
·
NACE 8622
Est. 2019 · 6 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Caroderma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
40
192
154
51
81
Staff expenses
−10
—
—
−8
—
EBITDA
−13
95
109
24
44
Depreciation & amort.
−0
−0
−0
—
−0
EBIT
−13
95
109
24
44
Net financials
0
1
—
−6
—
Profit before tax
−13
95
109
18
44
Tax
−0
−28
−23
−6
−9
Net profit
−13
67
86
12
35
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
81
208
278
128
163
Equity
68
121
204
118
105
Long-term debt
0
0
0
—
0
Short-term debt
13
88
74
10
58
Total debt
13
88
74
10
58
Financial ratios
5-year trend
EBITDA margin
-32.7%
This company
15.8%
Market median
This company
Market median
307% below market
2021
2025
Equity ratio
83.7%
This company
38.2%
Market median
This company
Market median
119% above market
2021
2025
Return on equity
-18.9%
This company
18.4%
Market median
This company
Market median
203% below market
2021
2025
Net profit margin
-31.9%
This company
8.1%
Market median
This company
Market median
494% below market
2021
2025
Asset turnover
0.49×
This company
1.12×
Market median
This company
Market median
56% below market
2021
2025
Debt / equity
0.20×
This company
0.62×
Market median
This company
Market median
68% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Caroderma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
